MCID: GNG002
MIFTS: 52

Ganglioneuroma

Categories: Cancer diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Ganglioneuroma

MalaCards integrated aliases for Ganglioneuroma:

Name: Ganglioneuroma 12 58 29 54 15 17 71

Classifications:

Orphanet: 58  
Rare neurological diseases


External Ids:

Disease Ontology 12 DOID:4817
MeSH 43 D005729
NCIt 49 C3049 C42065
ICD10 via Orphanet 33 D36.1
UMLS via Orphanet 72 C0017075
Orphanet 58 ORPHA251992
UMLS 71 C0017075 C1513025

Summaries for Ganglioneuroma

Disease Ontology : 12 An autonomic nervous system benign neoplasm that is characterized by the presence of mature ganglion cells and a mature Schwannian stroma and arises from the sympathetic trunk in the mediastinum.

MalaCards based summary : Ganglioneuroma is related to cutaneous ganglioneuroma and multiple endocrine neoplasia, type iia, and has symptoms including seizures An important gene associated with Ganglioneuroma is SYP (Synaptophysin), and among its related pathways/superpathways are Development HGF signaling pathway and Cytoskeleton remodeling Regulation of actin cytoskeleton by Rho GTPases. The drugs Dabrafenib and Trametinib have been mentioned in the context of this disorder. Affiliated tissues include adrenal gland, colon and bone, and related phenotypes are ganglioneuroma and colorectal polyposis

Wikipedia : 74 Ganglioneuroma is a rare and benign tumor of the autonomic nerve fibers arising from neural crest... more...

Related Diseases for Ganglioneuroma

Diseases related to Ganglioneuroma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 525)
# Related Disease Score Top Affiliating Genes
1 cutaneous ganglioneuroma 33.9 SYP NCAM1 ENO2 CHGA
2 multiple endocrine neoplasia, type iia 32.7 SYP RET NTRK1
3 appendix adenocarcinoma 32.2 SYP CHGA
4 gangliocytoma 32.1 TH SYP PTEN GFAP ENO2
5 central hypoventilation syndrome, congenital 32.0 TH RET NTRK2
6 rare tumor 31.0 SST RET
7 neurilemmoma 30.7 S100B GFAP ENO2
8 neurofibroma 30.6 SYP S100B PTEN
9 adenoma 30.5 SYP SST RET CHGA
10 adrenal cortical adenoma 30.4 SYP ENO2 CHGA
11 adrenal neuroblastoma 30.4 SYP NTRK1 MYCN ENO2
12 pheochromocytoma-paraganglioma 30.4 RET PNMT
13 thyroid carcinoma 30.4 RET PTEN NTRK1
14 myoblastoma 30.3 SYP ENO2
15 adrenal carcinoma 30.2 SYP SST ENO2 CHGA
16 multiple mucosal neuroma 30.1 RET NTRK1 ENO2
17 thyroid gland medullary carcinoma 30.0 SST RET NTRK1 CHGA
18 retroperitoneal neuroblastoma 30.0 MYCN ENO2 CD99
19 thyroid carcinoma, familial medullary 30.0 SST RET NTRK1 CHGA
20 ectomesenchymoma 30.0 ENO2 CD99
21 neuroma 30.0 S100B RET GFAP ENO2
22 cystic teratoma 30.0 SYP PTEN GFAP ENO2
23 vipoma 30.0 VIP SST CHGA
24 neurofibromatosis, type i 29.9 SST S100B RET NCAM1
25 nodular ganglioneuroblastoma 29.9 NTRK2 MYCN ENO2 CHGA
26 adrenal cortical carcinoma 29.9 SYP S100B CHGA
27 mediastinal cancer 29.8 SYP NCAM1 ENO2 CHGA
28 papillary carcinoma 29.8 SYP RET NTRK1 CHGA
29 benign ependymoma 29.7 SYP S100B GFAP ENO2
30 parachordoma 29.7 GFAP CHGA
31 extra-adrenal pheochromocytoma 29.6 SYP RET PNMT CHGA
32 endocrine gland cancer 29.3 VIP SYP SST RET CHGA
33 teratoma 29.1 SYP SST PTEN GFAP ENO2 CHGA
34 hemangioma 29.0 SYP RET PTEN ENO2 CHGA
35 ganglioneuroblastoma 29.0 VIP TH SYP S100B NTRK2 NTRK1
36 rhabdomyosarcoma 29.0 SYP S100B PTEN MYCN ENO2 CD99
37 olfactory neuroblastoma 29.0 SYP S100B NTRK1 ENO2 CHGA CD99
38 hirschsprung disease 1 28.8 VIP SYP RET NTRK3 NTRK1 NTF3
39 tuberous sclerosis 28.6 SYP SST S100B PTEN GFAP ENO2
40 neuroendocrine tumor 28.5 VIP SYP SST SCG2 RET NCAM1
41 malignant pheochromocytoma 28.3 TH SYP SST PNMT NCAM1 ENO2
42 pheochromocytoma 28.1 VIP TH SYP SST SCG2 RET
43 paraganglioma 28.1 TH SYP SST S100B RET PNMT
44 ewing sarcoma 28.0 SYP S100B RET NCAM1 MYCN ENO2
45 constipation 27.9 VIP TH SST S100B RET NTRK3
46 ganglioglioma 27.7 TH SYP S100B NTRK2 NTRK1 MYCN
47 neuroblastoma 27.2 VIP TH SYP SST RET PTEN
48 multiple endocrine neoplasia, type iib 11.7
49 neuroblastoma 1 11.2
50 adrenal gland pheochromocytoma 10.6

Graphical network of the top 20 diseases related to Ganglioneuroma:



Diseases related to Ganglioneuroma

Symptoms & Phenotypes for Ganglioneuroma

Human phenotypes related to Ganglioneuroma:

58 31 (show all 17)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 ganglioneuroma 58 31 obligate (100%) Obligate (100%) HP:0003005
2 colorectal polyposis 58 31 frequent (33%) Frequent (79-30%) HP:0200063
3 abnormality of the mediastinum 58 31 frequent (33%) Frequent (79-30%) HP:0045026
4 multiple intestinal neurofibromatosis 58 31 frequent (33%) Frequent (79-30%) HP:0005220
5 hypertension 58 31 occasional (7.5%) Occasional (29-5%) HP:0000822
6 hamartomatous polyposis 58 31 occasional (7.5%) Occasional (29-5%) HP:0004390
7 neoplasm of the adrenal gland 58 31 occasional (7.5%) Occasional (29-5%) HP:0100631
8 episodic abdominal pain 58 31 occasional (7.5%) Occasional (29-5%) HP:0002574
9 functional intestinal obstruction 58 31 occasional (7.5%) Occasional (29-5%) HP:0005249
10 gastrointestinal hemorrhage 58 31 very rare (1%) Very rare (<4-1%) HP:0002239
11 abnormal bone structure 58 31 very rare (1%) Very rare (<4-1%) HP:0003330
12 central hypoventilation 58 31 very rare (1%) Very rare (<4-1%) HP:0007110
13 abnormality of the orbital region 58 31 very rare (1%) Very rare (<4-1%) HP:0000315
14 abnormal prostate morphology 31 very rare (1%) HP:0008775
15 abnormality of the rectum 58 Very rare (<4-1%)
16 abnormality of the adrenal glands 58 Frequent (79-30%)
17 abnormality of the prostate 58 Very rare (<4-1%)

UMLS symptoms related to Ganglioneuroma:


seizures

MGI Mouse Phenotypes related to Ganglioneuroma:

45
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.38 ENO2 GALP GFAP MYCN NCAM1 NTF3
2 growth/size/body region MP:0005378 10.25 CHGA ENO2 GALP GFAP MYCN NTF3
3 homeostasis/metabolism MP:0005376 10.22 CHGA GALP GFAP MYCN NTF3 NTRK2
4 cardiovascular system MP:0005385 10.2 CHGA GFAP MYCN NTF3 NTRK3 PNMT
5 nervous system MP:0003631 10.2 CHGA ENO2 GFAP MYCN NCAM1 NTF3
6 mortality/aging MP:0010768 10.18 CHGA GFAP MYCN NCAM1 NTF3 NTRK1
7 normal MP:0002873 10 GFAP MYCN NTF3 NTRK1 NTRK2 NTRK3
8 no phenotypic analysis MP:0003012 9.8 CHGA MYCN NTRK1 NTRK3 RET SST
9 respiratory system MP:0005388 9.61 ENO2 MYCN NTF3 NTRK2 NTRK3 PTEN
10 vision/eye MP:0005391 9.32 GFAP MYCN NCAM1 NTF3 NTRK1 NTRK2

Drugs & Therapeutics for Ganglioneuroma

Drugs for Ganglioneuroma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 23)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Dabrafenib Approved, Investigational Phase 4 1195765-45-7 44462760 44516822
2
Trametinib Approved Phase 4 871700-17-3 11707110
3 Protein Kinase Inhibitors Phase 4
4
Vincristine Approved, Investigational Phase 2 57-22-7, 2068-78-2 5978
5
Carboplatin Approved Phase 2 41575-94-4 10339178 38904 498142
6 Tubulin Modulators Phase 2
7 Antimitotic Agents Phase 2
8
Irinotecan Approved, Investigational Phase 1 97682-44-5, 100286-90-6 60838
9
Bevacizumab Approved, Investigational Phase 1 216974-75-3
10 topoisomerase I inhibitors Phase 1
11 Angiogenesis Inhibitors Phase 1
12 Antineoplastic Agents, Immunological Phase 1
13
Etoposide Approved 33419-42-0 36462
14
Cyclophosphamide Approved, Investigational 50-18-0, 6055-19-2 2907
15
Cisplatin Approved 15663-27-1 2767 441203 84093
16 Immunologic Factors
17 Etoposide phosphate
18 Immunosuppressive Agents
19 Alkylating Agents
20 Antirheumatic Agents
21 Fluorodeoxyglucose F18
22 Edotreotide
23 Radiopharmaceuticals

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 An Open Label, Multi-center Roll-over Study to Assess Long-term Effect in Pediatric Patients Treated With Tafinlar (Dabrafenib) and/or Mekinist (Trametinib) Recruiting NCT03975829 Phase 4 dabrafenib;trametinib
2 Phase II Open-label Global Study to Evaluate the Effect of Dabrafenib in Combination With Trametinib in Children and Adolescent Patients With BRAF V600 Mutation Positive Low Grade Glioma (LGG) or Relapsed or Refractory High Grade Glioma (HGG) Recruiting NCT02684058 Phase 2 dabrafenib;trametinib;Carboplatin with vincristine
3 Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors, A Feasibility Study Completed NCT01999270 Phase 1 Irinotecan;Bevacizumab
4 Protocol for Infants With Neuroblastoma Diagnosed Under the Age of One Year Unknown status NCT00287950 carboplatin;cisplatin;cyclophosphamide;etoposide;vincristine sulfate
5 Utility of Gallium-68-DOTA-Octreotate PET/CT in the Characterization of Pediatric Neuroendocrine Tumors Recruiting NCT04040088 Early Phase 1 Gallium Ga 68-DOTATATE
6 Evaluation of the Safety and Sensitivity of 68Ga-DOTATOC PET/CT for Imaging NET Patients Recruiting NCT03583528
7 International Congenital Central Hypoventilation Syndrome (CCHS) REDCap Registry Recruiting NCT03088020
8 Protocol for the Enrollment on the Official COG Registry, The Childhood Cancer Research Network (CCRN) Children s Oncology Group Terminated NCT01117168

Search NIH Clinical Center for Ganglioneuroma

Genetic Tests for Ganglioneuroma

Genetic tests related to Ganglioneuroma:

# Genetic test Affiliating Genes
1 Ganglioneuroma 29

Anatomical Context for Ganglioneuroma

MalaCards organs/tissues related to Ganglioneuroma:

40
Adrenal Gland, Colon, Bone, Prostate, Spinal Cord, Brain, Pancreas

Publications for Ganglioneuroma

Articles related to Ganglioneuroma:

(show top 50) (show all 1574)
# Title Authors PMID Year
1
Ectopic Cushing's syndrome due to an adrenal ganglioneuroma. 61 54
20389113 2010
2
Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors. 61 54
16044164 2005
3
Adrenal ganglioneuromas in children with multiple endocrine neoplasia type 2: a report of two cases. 54 61
15827098 2005
4
TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance. 61 54
15386308 2004
5
Paraneoplastic syndromes in ganglioneuroblastoma: contrasting symptoms of constipation and diarrhoea. 54 61
12739135 2003
6
Real-time analysis of tyrosine hydroxylase gene expression: a sensitive and semiquantitative marker for minimal residual disease detection of neuroblastoma. 61 54
12576454 2003
7
Galanin and galanin receptor expression in neuroblastic tumours: correlation with their differentiation status. 61 54
11857022 2002
8
Neurotrophins and neurotrophin receptors in some neural crest-derived tumours (ganglioneuroma, phaeochromocytoma and paraganglioma). 61 54
10217562 1999
9
Thoracic paravertebral ganglioneuroma with high immunohistochemical expression of TrkA. 54 61
19519647 1999
10
CD44 expression in neuroblastoma and related tumors. 54 61
9256826 1997
11
Clinical relevance of TRKA expression on neuroblastoma: comparison with N-MYC amplification and CD44 expression. 61 54
9099963 1997
12
Pancreastatin immunoreactivity in favourable childhood neuroblastoma and ganglioneuroma. 54 61
7576967 1995
13
Somatostatin and vasoactive intestinal peptide (VIP) in neuroblastoma and ganglioneuroma: chromatographic characterisation and release during surgery. 54 61
7576950 1995
14
Tyrosine hydroxylase indicates cell differentiation of catecholamine biosynthesis in neuroendocrine tumors. 61 54
7523477 1994
15
Chromogranin A, secretogranin II and vasoactive intestinal peptide in phaeochromocytomas and ganglioneuromas. 61 54
8354485 1993
16
Extra-adrenal pheochromocytoma-ganglioneuroma. A case report. 54 61
1300605 1992
17
Nerve growth factor receptor expression in peripheral and central neuroectodermal tumors, other pediatric brain tumors, and during development of the adrenal gland. 54 61
1649553 1991
18
Laparoscopic excision of a large Adrenal Ganglioneuroma masquerading as Pheochromocytoma- A case report & review of literature. 61
32489900 2020
19
Non-adrenal tumors of the adrenal area; what are the pitfalls? 61
32201083 2020
20
Outcome of a dog undergoing definitive-intent intensity-modulated radiation therapy for an intranasal ganglioneuroma. 61
32542944 2020
21
Surgical management of peripheral nerve sheath tumours in children, with special consideration of neurofibromatoses. 61
32506255 2020
22
Role and toxicity of radiation therapy in neuroblastoma patients: A literature review. 61
32172225 2020
23
Mediastinal ganglioneuroma diagnosed by transesophageal endoscopic ultrasound guided fine needle aspiration (EUS-FNA). 61
32396276 2020
24
Intestinal ganglioneuroma in a neonatal Japanese black calf - Short communication. 61
32384067 2020
25
Large adrenal ganglioneuroma: A rare entity with atypical radiological characteristics. 61
32415649 2020
26
Neurogenic Tumors of the Mediastinum. 61
32448592 2020
27
Rare Images of a Peripancreatic Ganglioneuroma. 61
31839657 2020
28
A giant ganglioneuroma accompanied with scoliosis. 61
32233849 2020
29
Runt-related transcription factor 1 promotes apoptosis and inhibits neuroblastoma progression in vitro and in vivo. 61
32197643 2020
30
[Clinicopathological features of composite pheochromocytoma]. 61
32074727 2020
31
Colonic Neurogenic Lesion: An Admixture of Mucosal Neurofibromatous Lesion and Submucosal Ganglioneuromatous Lesion With Transition. 61
32028811 2020
32
Adrenal masses in children: Imaging, surgical treatment and outcome. 61
30962018 2020
33
Multimodal Imaging Features of Bilateral Choroidal Ganglioneuroma. 61
32454990 2020
34
Pathological Thoracic Spine Scoliosis Due to Ganglioneuroma. 61
31033504 2020
35
Giant intrathoracic ganglioneuroma with scoliosis treated by one-stage posterior resection and scoliosis correction: a case report. 61
32378512 2020
36
Postoperative Horner's syndrome following excision of incidental cervical ganglioneuroma during hemithyroidectomy and parathyroid gland exploration. 61
31969402 2020
37
Endoscopic Treatment of Solitary Colonic Ganglioneuroma. 61
32095122 2020
38
Paravertebral lipomatous ganglioneuroma with intraspinal extension. Case report and literature review. 61
31129025 2020
39
Mediastinal Hibernoma: A Rare Cause of Chronic Cough. 61
32133260 2020
40
Spontaneous regression of stage III neuroblastoma: A case report. 61
32047796 2020
41
An interesting cause of chronic abdominal pain in a child. 61
31530107 2020
42
The ganglioside GD2 as a circulating tumor biomarker for neuroblastoma. 61
31612589 2020
43
Transcervical excision combined with uniportal VATS for apical ganglioneuroma: a case report. 61
31929973 2019
44
Occurrence of paratesticular ganglioneuroma 18 years after concurrent adrenal ganglioneuroma and papillary thyroid carcinoma - a case report. 61
31888521 2019
45
[A Case of Neurofibromatosis Type 1 Presenting Voiding Symptoms Caused by Giant Bladder Diverticulum]. 61
31933336 2019
46
Concurrent Adrenal and Extra-Adrenal Ganglioneuromas: A Case Report. 61
31806861 2019
47
A radiological and histological comparison of two unusual adrenal incidentalomas. 61
31901917 2019
48
Importance of Magnetic Resonance Imaging With Diffusion-weighted Imaging in Guiding Biopsy of Nodular Ganglioneuroblastoma: A Case Report. 61
31815883 2019
49
Ganglioneuroma of the Phrenic Nerve: An Unusual Site. 61
31784346 2019
50
Cytopathological spectrum of peripheral neuroblastic tumours in fine needle aspiration cytology and categorisation as per International Neuroblastoma Pathology Classification. 61
31231909 2019

Variations for Ganglioneuroma

Expression for Ganglioneuroma

Search GEO for disease gene expression data for Ganglioneuroma.

Pathways for Ganglioneuroma

Pathways related to Ganglioneuroma according to GeneCards Suite gene sharing:

(show all 13)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.46 PTEN NTRK3 NTRK2 NTRK1 NTF3
2
Show member pathways
12.35 NTRK3 NTRK2 NTRK1 NTF3
3
Show member pathways
12.27 NTRK3 NTRK2 NTRK1 NTF3
5 11.94 VIP TH SYP S100B RET NTRK3
6 11.91 TH SST RET NTRK2
7 11.71 NTRK3 NTRK2 NTRK1 NTF3 NCAM1
8 11.47 RET PTEN NTRK3 NTRK1
9
Show member pathways
11.34 NTRK3 NTRK2 NTRK1 NTF3
10 11.33 TH SYP S100B NTF3 NCAM1 GFAP
11 11.2 NTRK3 NTRK2 NTRK1
12 10.81 NTRK3 NTRK2 NTRK1 NTF3 GFAP
13
Show member pathways
10.52 NTRK2 NTRK1

GO Terms for Ganglioneuroma

Cellular components related to Ganglioneuroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 10.09 VIP SST SCG2 S100B PTEN NTF3
2 dendrite GO:0030425 9.8 TH RET NTRK2 NTRK1 NTF3
3 neuron projection GO:0043005 9.77 VIP TH SYP PTEN NCAM1
4 receptor complex GO:0043235 9.62 RET NTRK3 NTRK2 NTRK1
5 neuronal cell body GO:0043025 9.43 TH SST S100B RET NTRK1 ENO2
6 terminal bouton GO:0043195 9.33 TH SYP NTRK2
7 neuronal dense core vesicle GO:0098992 9.26 SCG2 CHGA
8 axon GO:0030424 9.1 TH RET NTRK3 NTRK2 NTRK1 NTF3

Biological processes related to Ganglioneuroma according to GeneCards Suite gene sharing:

(show all 30)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of cell proliferation GO:0008284 10.03 VIP S100B PTEN NTRK3 NTRK2 NTF3
2 positive regulation of gene expression GO:0010628 10.02 RET PTEN NTRK3 NTRK2 MYCN
3 nervous system development GO:0007399 10.01 RET PTEN NTRK3 NTRK2 NTRK1 NTF3
4 response to drug GO:0042493 9.97 TH SST RET PTEN NTRK1
5 positive regulation of ERK1 and ERK2 cascade GO:0070374 9.91 PTEN NTRK3 NTRK2 NTRK1
6 peptidyl-tyrosine phosphorylation GO:0018108 9.88 RET NTRK3 NTRK2 NTRK1
7 positive regulation of neuron projection development GO:0010976 9.85 RET NTRK3 NTRK2 NTRK1
8 positive regulation of MAPK cascade GO:0043410 9.83 RET NTRK3 NTRK2 NTRK1
9 circadian rhythm GO:0007623 9.82 NTRK3 NTRK2 NTRK1
10 positive regulation of peptidyl-serine phosphorylation GO:0033138 9.8 NTRK3 NTRK2 NTF3
11 positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068 9.78 NTRK3 NTRK2 NTRK1 NTF3
12 positive regulation of synapse assembly GO:0051965 9.77 NTRK3 NTRK2 NTRK1
13 memory GO:0007613 9.76 TH S100B PTEN NTF3
14 positive regulation of kinase activity GO:0033674 9.73 RET NTRK3 NTRK2 NTRK1
15 transmembrane receptor protein tyrosine kinase signaling pathway GO:0007169 9.72 RET NTRK3 NTRK2 NTRK1 NTF3
16 learning or memory GO:0007611 9.71 VIP S100B PTEN NTRK1
17 regulation of MAPK cascade GO:0043408 9.69 NTRK3 NTRK2 NTRK1
18 long-term synaptic potentiation GO:0060291 9.67 S100B PTEN NTRK2 GFAP
19 induction of positive chemotaxis GO:0050930 9.65 SCG2 NTF3
20 nerve growth factor signaling pathway GO:0038180 9.64 NTRK1 NTF3
21 positive regulation of phospholipase C activity GO:0010863 9.63 NTRK3 NTF3
22 cellular response to nicotine GO:0071316 9.62 TH NTRK1
23 neuronal action potential propagation GO:0019227 9.61 NTRK3 NTRK2
24 positive regulation of neurotrophin TRK receptor signaling pathway GO:0051388 9.59 NTRK3 NTF3
25 catecholamine biosynthetic process GO:0042423 9.58 TH PNMT
26 cellular response to nerve growth factor stimulus GO:1990090 9.56 PTEN NTRK3 NTRK2 NTRK1
27 epinephrine biosynthetic process GO:0042418 9.49 TH PNMT
28 mechanoreceptor differentiation GO:0042490 9.33 NTRK3 NTRK2 NTRK1
29 neurotrophin signaling pathway GO:0038179 9.13 NTRK3 NTRK2 NTRK1
30 regulation of protein kinase B signaling GO:0051896 8.92 PTEN NTRK3 NTRK2 NTRK1

Molecular functions related to Ganglioneuroma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 protein tyrosine kinase activity GO:0004713 9.56 RET NTRK3 NTRK2 NTRK1
2 transmembrane receptor protein tyrosine kinase activity GO:0004714 9.46 RET NTRK3 NTRK2 NTRK1
3 GPI-linked ephrin receptor activity GO:0005004 9.32 NTRK3 NTRK1
4 neurotrophin binding GO:0043121 9.13 NTRK3 NTRK2 NTRK1
5 neurotrophin receptor activity GO:0005030 8.8 NTRK3 NTRK2 NTRK1

Sources for Ganglioneuroma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....